T Cells Redirected Against Hepatitis B Virus Surface Proteins Eliminate Infected Hepatocytes

Gastroenterology

Volumn 134, Issue 1, 2008, Pages 239-247

  Bohne, Felix ^a   Chmielewski, Markus ^a   Ebert, Gregor ^a   Wiegmann, Katja ^b   Kürschner, Timo ^c   Schulze, Andreas ^d   Urban, Stephan ^d   Krönke, Martin ^a,b   Abken, Hinrich ^a   Protzer, Ulrike ^a,e  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b Institute for Medical Microbiology   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD28 ANTIGEN; CD3 ANTIGEN; CD3 XI ANTIGEN; CHIMERIC PROTEIN; DIHYDROLIPOAMIDE DEHYDROGENASE; DNA; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 2; MEMBRANE PROTEIN; RETROVIRUS VECTOR; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VITRONECTIN;

ANTIBODY SPECIFICITY; ARTICLE; CELL DIVISION; CELL SURFACE; CYTOTOXIC T LYMPHOCYTE; EMBRYO; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL; MOLECULAR RECOGNITION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 37349056697     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.11.002     Document Type: Article

References (29)

1. Chisari F.V., and Ferrari C. Hepatitis B virus immunopathology. Springer Semin Immunopathol 17 (1995) 261-281
2. Rehermann B., Fowler P., Sidney J., et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 181 (1995) 1047-1058
3. Penna A., Chisari F.V., Bertoletti A., et al. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med 174 (1991) 1565-1570
4. Wieland S.F., Spangenberg H.C., Thimme R., et al. Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees. Proc Natl Acad Sci U S A 101 (2004) 2129-2134
5. Ganem D., and Prince A.M. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 350 (2004) 1118-1129
6. Wursthorn K., Lutgehetmann M., Dandri M., et al. Peginterferon α-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Hepatology 44 (2006) 675-684
7. Rooney C.M., Smith C.A., Ng C.Y., et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345 (1995) 9-13
8. Walter E.A., Greenberg P.D., Gilbert M.J., et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 333 (1995) 1038-1044
9. Morgan R.A., Dudley M.E., Wunderlich J.R., et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314 (2006) 126-129
10. Gattinoni L., Powell Jr. D.J., Rosenberg S.A., et al. Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol 6 (2006) 383-393
11. Eshhar Z., Waks T., Gross G., et al. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the γ or ξ subunits of the immunoglobulin and T-cell receptors. Proc Natl Acad Sci U S A 90 (1993) 720-724
12. Abken H., Hombach A., Heuser C., et al. Tuning tumor-specific T-cell activation: a matter of costimulation?. Trends Immunol 23 (2002) 240-245
13. Masiero S., Del Vecchio C., Gavioli R., et al. T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120. Gene Ther 12 (2005) 299-310
14. Sells M.A., Chen M.L., and Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A 84 (1987) 1005-1009
15. Schulze-Bergkamen H., Untergasser A., Dax A., et al. Primary human hepatocytes-a valuable tool for investigation of apoptosis and hepatitis B virus infection. J Hepatol 38 (2003) 736-744
16. Untergasser A., Zedler U., Langenkamp A., et al. Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection. Hepatology 43 (2006) 539-547
17. Pizarro J.C., Vulliez-le Normand B., Riottot M.M., et al. Structural and functional characterization of a monoclonal antibody specific for the preS1 region of hepatitis B virus. FEBS Lett 509 (2001) 463-468
18. Hombach A., Sent D., Schneider C., et al. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis. Cancer Res 61 (2001) 1976-1982
19. Weijtens M.E., Willemsen R.A., Hart E.H., et al. A retroviral vector system "STITCH" in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes. Gene Ther 5 (1998) 1195-1203
20. Betts M.R., Brenchley J.M., Price D.A., et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281 (2003) 65-78
21. Chu C.M., and Liaw Y.F. Membrane staining for hepatitis B surface antigen on hepatocytes: a sensitive and specific marker of active viral replication in hepatitis B. J Clin Pathol 48 (1995) 470-473
22. Gorelick F.S., and Shugrue C. Exiting the endoplasmic reticulum. Mol Cell Endocrinol 177 (2001) 13-18
23. Dumortier J., Schonig K., Oberwinkler H., et al. Liver-specific expression of interferon γ following adenoviral gene transfer controls hepatitis B virus replication in mice. Gene Ther 12 (2005) 668-677
24. Hombach A., Muche J.M., Gerken M., et al. T cells engrafted with a recombinant anti-CD30 receptor target autologous CD30(+) cutaneous lymphoma cells. Gene Ther 8 (2001) 891-895
25. Ganem D., and Schneider R. Hepadnaviridae. The viruses and their replication. Field's virology. 4th ed. (2001), Lipincott-Raven, Philadelphia
26. Hombach A., Koch D., Sircar R., et al. A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA. Gene Ther 6 (1999) 300-304
27. Kolanus W., Romeo C., and Seed B. T-cell activation by clustered tyrosine kinases. Cell 74 (1993) 171-183
28. Hombach A., Kohler H., Rappl G., et al. Human CD4+ T cells lyse target cells via granzyme/perforin upon circumvention of MHC class II restriction by an antibody-like immunoreceptor. J Immunol 177 (2006) 5668-5675
29. Enari M., Sakahira H., Yokoyama H., et al. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391 (1998) 43-50